Search Results
264 items found for "Prognostic model"
- Glyco-sulfo hotspots in the chemokine receptor system
chemokine receptors with their cognate chemokine ligands is generally described by the two-step/two-site model Within the CRS1 ineraction mode, the N-terminal region of chemokine receptors is indispensable for chemokine Probing the modulation of O-glycosylation and tyrosine sulfation on CCR5 and CCR1 function In this study mutagenesis approaches were performed to evaluate the effects of O-glycosylation and tyrosine sulfation modulation It remains to be discovered how much the modulation of these PTMs is relevant for future drug design.
- Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or sy
Methods: Using a widely adopted rodent model of 3-day recurrent hypoglycemia, we first checked expression The abovementioned studies were repeated in streptozotocin-induced diabetic rat model.
- Targeting Intracellular Allosteric Sites in GPCRs
Unlike orthosteric ligands that bind directly to the receptor's active site, allosteric modulators target Over the past decade, there has been a notable growth in the discovery of allosteric modulators for GPCRs functional and/or affinity for an orthosteric ligand; and negative allosteric modulators (NAMs), that In this context, allosteric modulators exhibiting constrained positive or negative cooperativity are SBI-553, an allosteric modulator of NTSR1, provides valuable insights into how allosteric modulation
- 📰 GPCR Weekly News, July 24 to July 30, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities is on September 22nd. Structural and Molecular Insights into GPCR Function Ternary model structural complex of C5a, C5aR2,
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
August 2022 "Abstract Rodent models are commonly used to evaluate parathyroid hormone (PTH) and PTH-related This introduces an element of uncertainty in the accuracy of rodent models for performing such preclinical
- 📰 GPCR Weekly News, September 18 to 24, 2023
GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! functional survival of human islets AT2 receptor agonist LP2 restores respiratory function in a rat model
- 📰 GPCR Weekly News, March 6 to 12, 2023
Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization modulates
- 📰 GPCR Weekly News, February 26 to March 3, 2024
acid substitution G protein-coupled receptors: from radioligand binding to cellular signaling GPR101: Modeling potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid modulation
- Chemokine receptor-targeted drug discovery: progress and challenges
receptors can homo- and hetero-oligomerize, impacting receptor/ligand-binding and signaling patterns, by modulating These larger interfaces represent the typical protein-protein interactions which are difficult to modulate Overall, the future potential lies in using different therapeutic modalities to modulate the stromal
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs FSHR activation through small molecule modulators: Mechanistic insights from MD simulations. Structural and Molecular Insights into GPCR Function The activation mechanism and antibody binding mode
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model
- Molecular targets of psychedelic-induced plasticity
of the most recent findings in human studies and contextualize them considering previous preclinical models
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Xenograft mouse model was generated to investigate the in vivo efficacy of fentanyl.
- 📰 GPCR Weekly News, December 18 to 31, 2023
Tribolium castaneum GPCR Activation and Signaling Palmitoylation of the Glucagon-like Peptide-1 Receptor Modulates Binding Methods to Measure Receptor-Ligand Interactions How accurately can one predict drug binding modes using AlphaFold models?
- 📰 GPCR Weekly News, May 6 to 12, 2024
CCR6 for Autoimmune Diseases MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse model inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model Glycoprotein-glycoprotein receptor binding detection using bioluminescence resonance energy transfer Bayesian network models
- Emerging approaches for decoding neuropeptide transmission
high-resolution techniques to investigate peptidergic transmission and expression throughout the brain in model
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
most significant groups of G-protein coupled receptor (GPCR) drug targets and also act as prototypical models
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
subcellular localization and activity in a polarized epithelium using the Drosophila wing imaginal disc as a model
- Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inv
Our model not only shows the function of dimeric β2-AR but also provides a molecular insight into the
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
tuberculosis adenylyl cyclase (AC) Rv1625c/Cya is an evolutionary ancestor of the mammalian membrane ACs and a model
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
residues that influence efficacy and potency, pharmaceutical researchers can create drugs that precisely modulate The study distinguishes between driver residues , which directly influence signal transduction, and modulator Alternatively, allosteric modulators , which bind to sites outside the traditional ligand-binding pocket Allosteric modulators offer a promising approach for developing drugs that enhance or inhibit receptor within the ligand-binding pocket, resulting in a significant opportunity for developing allosteric modulators
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
In a LPS-induced lung inflammation model in mice, ACT-660602 led to significantly reduced recruitment
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
CXCR1/2 inhibitors show beneficial effects in various animal models of CVD.
- Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to...
Our model not only shows the function of dimeric β2-AR but also provides a molecular insight into the
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
CXCR1/2 inhibitors show beneficial effects in various animal models of CVD.
- Multifunctional role of GPCR signaling in epithelial tube formation
Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent
- Multifunctional role of GPCR signaling in epithelial tube formation
Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent
- Location bias contributes to functionally selective responses of biased CXCR3 agonists
In a mouse model of contact hypersensitivity, β-arrestin-biased CXCR3-mediated inflammation is dependent